 Home > Medical News > Medicines Company News > Luye Pharma's next-generation VMAT2 inhibitor submits clinical trial application in the U.S.

Luye Pharma's next-generation VMAT2 inhibitor submits clinical trial application in the U.S.

 Last Update: 2021-08-04
 Source: Internet
 Author: User

Tags

moon phase clock

tetrabenazine tardive dyskinesia

single use technology

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On August 2, Luye Pharmaceutical Group announced that its self-developed new generation of vesicle monoamine transporter 2 (VMAT2) inhibitor LY03015 has submitted a clinical trial application in the United States and will soon enter the phase I clinical phase
.

LY03015 is used for the treatment of tardive dyskinesia (TD) and Huntington's disease (HD).

The Phase I clinical trial of LY03015 in the United States is a single-center, randomized, double-blind, placebo-controlled, single-dose, dose-escalating trial design, aiming to evaluate the safety of a single oral dose of LY03015 in healthy subjects , Tolerability and pharmacokinetic characteristics, and plan to enroll 120 subjects
.

In addition to the United States, clinical trials of LY03015 will also be carried out simultaneously in China

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.